Major Shareholding Notification • Feb 23, 2023
Major Shareholding Notification
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 8890Q
Logistics Development Group PLC
23 February 2023
23 February 2023
Logistics Development Group plc
("LDG") or the "Company")
Further Alliance Pharma plc Investment
LDG is pleased to announce that, further to its announcement on 22 December 2022, it has purchased an additional 18,686,042 ordinary shares in Alliance Pharma plc ("Alliance") (LON:APH), at an average price of £0.5911 per ordinary share, for a total cash consideration of £3,452,782.
Following these purchases, LDG is interested in approximately 3.46% of Alliance's issued share capital.
Alliance is an international healthcare group founded in 1996 and headquartered in the United Kingdom. The company acquires, markets, and distributes consumer healthcare and prescription medicine products.
For the year ended 31 December 2021, Alliance reported an underlying pre-tax profit of £42.2 million. As at 30 June 2022, Alliance reported net assets of £296.9 million.
For enquiries:
| Logistics Development Group plc | Via FTI Consulting |
| FTI Consulting Nick Hasell Alex Le May Cally Billimore |
+44 (0) 20 3727 1340 |
| Strand Hanson Limited (Financial and Nominated Adviser) James Spinney James Dance Abigail Wennington |
+44 (0) 20 7409 3494 |
| Investec Bank plc (Broker) Gary Clarence Harry Hargreaves |
+44 (0) 20 7597 5970 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCXXLFLXLLLBBD
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.